BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29398354)

  • 1. A Machine Learning Approach to Identifying Placebo Responders in Late-Life Depression Trials.
    Zilcha-Mano S; Roose SP; Brown PJ; Rutherford BR
    Am J Geriatr Psychiatry; 2018 Jun; 26(6):669-677. PubMed ID: 29398354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrupt Symptom Improvements in Antidepressant Clinical Trials: Transient Placebo Effects or Therapeutic Reality?
    Zilcha-Mano S; Roose SP; Brown PJ; Rutherford BR
    J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Symptom Trajectories as Predictors of Treatment Outcome for Citalopram Versus Placebo.
    Zilcha-Mano S; Roose SP; Brown PJ; Rutherford BR
    Am J Geriatr Psychiatry; 2017 Jun; 25(6):654-661. PubMed ID: 28318797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response.
    Yuen GS; Gunning FM; Woods E; Klimstra SA; Hoptman MJ; Alexopoulos GS
    J Affect Disord; 2014 Sep; 166():179-86. PubMed ID: 25012429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo response and antidepressant response.
    Alexopoulos GS; Kanellopoulos D; Murphy C; Gunning-Dixon F; Katz R; Heo M
    Am J Geriatr Psychiatry; 2007 Feb; 15(2):149-58. PubMed ID: 17272735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.
    Noma H; Furukawa TA; Maruo K; Imai H; Shinohara K; Tanaka S; Ikeda K; Yamawaki S; Cipriani A
    J Affect Disord; 2019 May; 250():419-424. PubMed ID: 30878654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
    Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S
    Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.
    Habra ME; Baker B; Frasure-Smith N; Swenson JR; Koszycki D; Butler G; van Zyl LT; Lespérance F
    J Psychosom Res; 2010 Aug; 69(2):133-41. PubMed ID: 20624511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderators of outcome in late-life depression: a patient-level meta-analysis.
    Nelson JC; Delucchi KL; Schneider LS
    Am J Psychiatry; 2013 Jun; 170(6):651-9. PubMed ID: 23598969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram in first episode schizophrenia: The DECIFER trial.
    Goff DC; Freudenreich O; Cather C; Holt D; Bello I; Diminich E; Tang Y; Ardekani BA; Worthington M; Zeng B; Wu R; Fan X; Li C; Troxel A; Wang J; Zhao J
    Schizophr Res; 2019 Jun; 208():331-337. PubMed ID: 30709746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.
    Kraus MR; Schäfer A; Schöttker K; Keicher C; Weissbrich B; Hofbauer I; Scheurlen M
    Gut; 2008 Apr; 57(4):531-6. PubMed ID: 18079286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Debunking the placebo effect in depression: the effect of patient and investigator expectation on escitalopram efficacy.
    Nehama Y; Rabinowitz I; Baruch Y; Mandel A; Lurie I; Barak Y
    Int Clin Psychopharmacol; 2014 Mar; 29(2):106-10. PubMed ID: 24172161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Failed Antidepressant Trials on Outcomes in Children and Adolescents with Anxiety and Depression: A Systematic Review and Meta-Analysis.
    Mossman SA; Mills JA; Walkup JT; Strawn JR
    J Child Adolesc Psychopharmacol; 2021 May; 31(4):259-267. PubMed ID: 33887154
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.
    von Knorring AL; Olsson GI; Thomsen PH; Lemming OM; Hultén A
    J Clin Psychopharmacol; 2006 Jun; 26(3):311-5. PubMed ID: 16702897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram versus other anti-depressive agents for depression.
    Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C
    Cochrane Database Syst Rev; 2012 Jul; 7(7):CD006534. PubMed ID: 22786497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in cognitive functioning following acute antidepressant treatment in late-life depression.
    Culang ME; Sneed JR; Keilp JG; Rutherford BR; Pelton GH; Devanand DP; Roose SP
    Am J Geriatr Psychiatry; 2009 Oct; 17(10):881-8. PubMed ID: 19916207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.